Structures by: Zouihri H.
Total: 102
C22H26N2O6
C22H26N2O6
Molbank (2020) 2020, 4 M1163
a=15.8302(5)Å b=10.1380(3)Å c=14.2916(7)Å
α=90° β=114.2670(10)° γ=90°
4-Methyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C10H10N2O
IUCrData (2018) 3, 12 x181718
a=7.5676(2)Å b=10.7802(2)Å c=11.4092(3)Å
α=90° β=90° γ=90°
Dithiobis(formamidinium) bis(hydrogen sulfate)
C2H8N4S22,2(HO4S)
IUCrData (2018) 3, 11 x181540
a=5.1371(2)Å b=9.5237(4)Å c=12.9884(6)Å
α=106.521(2)° β=96.067(2)° γ=95.618(2)°
2-[(<i>E</i>)-{[3-(1<i>H</i>-Imidazol-1-yl)propyl]imino}methyl]-4-[(<i>E</i>)-(4-methylphenyl)diazenyl]phenol
C20H21N5O
IUCrData (2019) 4, 1 x190036
a=12.2410(4)Å b=5.9386(2)Å c=25.2112(9)Å
α=90° β=90.317(3)° γ=90°
1,1'-(Hexane-1,6-diyl)bis(indoline-2,3-dione)
C22H20N2O4
IUCrData (2016) 1, 4 x160542
a=15.1498(3)Å b=7.4949(2)Å c=16.4795(3)Å
α=90° β=90° γ=90°
Poly[di-μ~2~-acetato-κ^4^<i>O</i>:<i>O</i>-μ~3~-thiourea-κ^3^<i>S</i>:<i>S</i>:<i>S</i>-lead(II)]
C5H10N2O4PbS
IUCrData (2016) 1, 12 x161892
a=4.4865(2)Å b=15.7001(5)Å c=13.6313(5)Å
α=90° β=91.481(2)° γ=90°
Piperazine-1,4-diium bis(3-carboxy-2,3-dihydroxypropanoate)
0.5(C4H12N22),C4H5O6
IUCrData (2017) 2, 2 x170249
a=7.54460(10)Å b=7.54460(10)Å c=27.6498(5)Å
α=90° β=90° γ=90°
1-[(2<i>E</i>)-3-Phenylprop-2-en-1-yl]-1<i>H</i>-indole-2,3-dione
C17H13NO2
IUCrData (2016) 1, 4 x160633
a=8.2585(2)Å b=7.26770(10)Å c=44.4667(8)Å
α=90° β=90° γ=90°
1-(3-Bromopropyl)indoline-2,3-dione
C11H10BrNO2
IUCrData (2016) 1, 4 x160593
a=7.7113(2)Å b=8.1375(2)Å c=17.8089(4)Å
α=90° β=93.8300(13)° γ=90°
1-Propyl-1<i>H</i>-indole-2,3-dione
C11H11NO2
IUCrData (2016) 1, 4 x160609
a=4.4666(2)Å b=12.9169(6)Å c=16.3857(8)Å
α=90° β=90° γ=90°
<i>catena</i>-Poly[[chloridolead(II)]-μ~2~-chlorido-di-μ~2~-thiourea-κ^2^<i>S</i>:<i>S</i>]
C2H8Cl2N4PbS2
IUCrData (2016) 1, 11 x161745
a=21.1951(6)Å b=4.02800(10)Å c=11.9433(3)Å
α=90° β=90° γ=90°
6-Bromo-2-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C7H6BrN3
IUCrData (2016) 1, 5 x160766
a=11.0395(12)Å b=6.4734(7)Å c=11.1397(12)Å
α=90° β=98.8890(10)° γ=90°
6-Bromo-2-(4-chlorophenyl)-3-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C13H9BrClN3
IUCrData (2016) 1, 5 x160763
a=12.1163(2)Å b=9.7911(2)Å c=20.9428(4)Å
α=90° β=90° γ=90°
Ethyl 2-(6-bromo-2-phenyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-1-yl)acetate
C16H14BrN3O2
IUCrData (2016) 1, 5 x160771
a=14.6923(8)Å b=6.1988(3)Å c=16.2254(8)Å
α=90° β=92.9110(10)° γ=90°
(2<i>Z</i>)-4-Benzyl-[(4-chlorophenyl)methylidene]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H16ClNOS
IUCrData (2016) 1, 5 x160764
a=11.8931(11)Å b=6.5358(6)Å c=22.817(2)Å
α=90° β=93.2390(10)° γ=90°
2-(2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetohydrazide monohydrate
C8H11N7O,H2O
IUCrData (2016) 1, 6 x160870
a=7.2648(3)Å b=8.7228(4)Å c=8.9297(4)Å
α=82.834(2)° β=71.465(2)° γ=85.4780(10)°
2-[(2<i>Z</i>)-2-Benzylidene-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl]acetic acid
C17H13NO3S
IUCrData (2016) 1, 6 x160863
a=8.6760(3)Å b=8.7882(3)Å c=9.8142(4)Å
α=78.2000(10)° β=73.3110(10)° γ=86.2420(10)°
1-Allyl-5-chloroindoline-2,3-dione
C11H8ClNO2
IUCrData (2016) 1, 6 x160862
a=31.2222(6)Å b=7.9107(2)Å c=8.3373(2)Å
α=90° β=90° γ=90°
5-Bromo-1-(6-bromohexyl)indoline-2,3-dione
C14H15Br2NO2
IUCrData (2016) 1, 6 x160883
a=4.6344(2)Å b=12.6284(6)Å c=25.3537(12)Å
α=90° β=90° γ=90°
1-Benzyl-5-chloroindoline-2,3-dione
C15H10ClNO2
IUCrData (2016) 1, 6 x160854
a=4.4576(2)Å b=27.6646(11)Å c=20.9530(8)Å
α=90° β=93.870(2)° γ=90°
5-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
IUCrData (2016) 1, 6 x160913
a=3.9766(4)Å b=11.9503(13)Å c=17.947(2)Å
α=90° β=96.163(3)° γ=90°
Methyl (2<i>R</i>)-2-benzamido-2-{[(1<i>R</i>)-2-methoxy-2-oxo-1-phenylethyl]amino}acetate
C19H20N2O5
IUCrData (2017) 2, 8 x171155
a=9.3432(6)Å b=10.4314(8)Å c=18.0901(14)Å
α=90.00° β=90.00° γ=90.00°
Dibenzyl({1-[(4-methyl-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-4-yl}methyl)amine
C28H29N5O
IUCrData (2017) 2, 6 x170860
a=9.8940(3)Å b=10.1125(2)Å c=24.8655(7)Å
α=90° β=95.0960(10)° γ=90°
2-Oxo-1,2-dihydroquinoline-4-carboxylic acid monohydrate
C10H7NO3,H2O
IUCrData (2016) 1, 6 x160997
a=20.7884(8)Å b=3.72150(10)Å c=23.8849(9)Å
α=90° β=98.582(2)° γ=90°
1-(12-Bromododecyl)-5-chloroindoline-2,3-dione
C20H27BrClNO2
IUCrData (2016) 1, 6 x160971
a=8.0353(4)Å b=8.3496(5)Å c=17.1096(11)Å
α=84.491(3)° β=78.086(3)° γ=65.126(2)°
1,5-Diethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dithione
C13H16N2S2
Acta Crystallographica Section E (2015) 71, 2 o83
a=19.8896(2)Å b=8.87430(10)Å c=15.5361(2)Å
α=90.00° β=104.0870(10)° γ=90.00°
N-(cyanomethyl)benzamide
C9H8N2O
Acta Crystallographica Section E (2010) 66, 3 o530
a=9.8623(5)Å b=8.0576(4)Å c=20.9268(9)Å
α=90.00° β=90.00° γ=90.00°
1-Allyl-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one
C18H16N2O
Acta Crystallographica Section E (2010) 66, 6 o1277
a=11.4863(3)Å b=6.0053(2)Å c=20.3667(5)Å
α=90.00° β=93.5250(10)° γ=90.00°
1-(1-Nonyl-2-oxoindolin-3-ylidene)thiosemicarbazide
C18H26N4OS
Acta Crystallographica Section E (2010) 66, 6 o1332
a=11.5343(2)Å b=10.5921(2)Å c=15.6262(3)Å
α=90.00° β=95.9220(10)° γ=90.00°
1-(1-Decyl-2-oxoindolin-3-ylidene)thiosemicarbazide
C19H28N4OS
Acta Crystallographica Section E (2010) 66, 6 o1333
a=11.8856(2)Å b=11.0055(2)Å c=15.1638(3)Å
α=90.00° β=99.4680(10)° γ=90.00°
1-Tetradecylindoline-2,3-dione
C22H33NO2
Acta Crystallographica Section E (2010) 66, 6 o1410
a=27.6647(8)Å b=4.70550(10)Å c=15.7583(5)Å
α=90.00° β=103.6350(10)° γ=90.00°
1-Decylindoline-2,3-dione
C18H25NO2
Acta Crystallographica Section E (2010) 66, 6 o1411
a=22.7208(3)Å b=4.71890(10)Å c=15.82540(10)Å
α=90.00° β=106.8270(10)° γ=90.00°
4-<i>tert</i>-Butyl-4'-(4-methoxyphenyl)-3'-(4-methylphenyl)- 1,2,3,4-tetrahydrospiro[naphthalene-2,5'(4'<i>H</i>)-1,2-oxazol]-1-one
C30H31NO3
Acta Crystallographica Section E (2010) 66, 11 o3040
a=6.9248(3)Å b=24.7919(12)Å c=14.2111(7)Å
α=90.00° β=94.460(2)° γ=90.00°
2-(1,3-Dioxoisoindolin-2-yl)acetonitrile
C10H6N2O2
Acta Crystallographica Section E (2010) 66, 10 o2631
a=8.0960(2)Å b=8.4371(2)Å c=14.3118(3)Å
α=85.0720(10)° β=79.2720(10)° γ=68.4210(10)°
Methyl 2-(3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl)acetate
C11H11NO3S
Acta Crystallographica Section E (2011) 67, 3 o724
a=17.347(5)Å b=8.724(2)Å c=7.2740(10)Å
α=90.00° β=98.71(2)° γ=90.00°
3-Methyl-1-(prop-2-en-1-yl)quinoxalin-2(1<i>H</i>)-one
C12H12N2O
Acta Crystallographica Section E (2010) 66, 7 o1767
a=5.0722(5)Å b=13.4707(13)Å c=15.0507(13)Å
α=90.00° β=95.082(5)° γ=90.00°
10-(Prop-2-ynyl)-10<i>H</i>-phenothiazine
C15H11NS
Acta Crystallographica Section E (2010) 66, 11 o2830
a=10.5306(10)Å b=7.2981(6)Å c=15.6782(14)Å
α=90.00° β=96.023(3)° γ=90.00°
3-[2-(5<i>H</i>-Indolo[2,3-<i>b</i>]quinoxalin-5-yl)ethyl]-1,3-oxazolidin-2-one
C19H16N4O2
Acta Crystallographica Section E (2010) 66, 9 o2461
a=14.5565(4)Å b=5.8993(2)Å c=18.6434(6)Å
α=90.00° β=92.393(2)° γ=90.00°
1,3-Diallyl-2-methylbenzimidazolium bromide dihydrate
C14H17N2,Br,2H2O
Acta Crystallographica Section E (2009) 65, 10 o2321
a=13.2888(2)Å b=16.8763(2)Å c=7.38970(10)Å
α=90.00° β=109.7730(10)° γ=90.00°
1-Allyl-3-chloro-6-nitro-1<i>H</i>-indazole
C10H8ClN3O2
Acta Crystallographica Section E (2009) 65, 10 o2320
a=7.68040(10)Å b=9.9559(2)Å c=28.4344(4)Å
α=90° β=95.1440(10)° γ=90°
3-[2-(2,3-dioxoindolin-1-yl)ethyl]-1,3-oxazolidin-2-one
C13H12N2O4
Acta Crystallographica Section E (2010) 66, 2 o454
a=7.1198(2)Å b=7.4694(2)Å c=12.0319(3)Å
α=83.338(2)° β=79.084(2)° γ=81.372(2)°
1,3-Dibenzyl-2-methylbenzimidazolium chloride
C22H21N2,Cl
Acta Crystallographica Section E (2010) 66, 2 o455
a=9.2539(2)Å b=9.4677(2)Å c=12.0984(3)Å
α=72.1390(10)° β=81.3760(10)° γ=64.6050(10)°
3-(Phenylimino)indolin-2-one
C14H10N2O
Acta Crystallographica Section E (2010) 66, 2 o453
a=20.1647(4)Å b=5.02230(10)Å c=21.8791(5)Å
α=90.00° β=90.00° γ=90.00°
2-Hydroxy-10-propargylpyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dione monohydrate
C15H14N2O3,H2O
Acta Crystallographica Section E (2010) 66, 4 o731
a=6.89770(10)Å b=7.97610(10)Å c=13.0680(2)Å
α=90.00° β=99.1940(10)° γ=90.00°
2-Hydroxy-10-phenacylpyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dione
C20H18N2O4
Acta Crystallographica Section E (2010) 66, 4 o732
a=8.8337(2)Å b=9.9476(2)Å c=18.9295(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-hydroxy-5,11-dioxopyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-10-acetate
C16H18N2O5
Acta Crystallographica Section E (2010) 66, 4 o733
a=8.5503(2)Å b=9.6580(2)Å c=18.2734(4)Å
α=90.00° β=90.00° γ=90.00°
2-Methyl-3-(<i>n</i>-octylsulfanyl)quinoxaline
C17H24N2S
Acta Crystallographica Section E (2010) 66, 4 o992
a=7.3514(3)Å b=8.2978(3)Å c=14.2168(5)Å
α=92.275(2)° β=98.706(2)° γ=103.810(2)°
Diethyl 2-{(dibenzylamino)[4-(trifluoromethyl)phenyl]methyl}malonate
C29H30F3NO4
Acta Crystallographica Section E (2010) 66, 4 o961-o962
a=13.4131(3)Å b=23.6608(5)Å c=17.3769(3)Å
α=90.00° β=96.8260(10)° γ=90.00°
Diethyl 2-[(<i>N</i>-benzyl-<i>N</i>-methylamino)(phenyl)methyl]propanedioate
C22H27NO4
Acta Crystallographica Section E (2010) 66, 4 o746
a=9.3074(2)Å b=5.90770(10)Å c=37.0971(7)Å
α=90.00° β=92.9990(10)° γ=90.00°
1-Benzyl-3-[(dimethylamino)methylene]-4-phenyl-1<i>H</i>-1,5-benzodiazepine- 2(3<i>H</i>)-thione
C25H23N3S
Acta Crystallographica Section E (2010) 66, 5 o1019
a=26.4740(8)Å b=10.2366(2)Å c=16.5650(5)Å
α=90.00° β=106.1360(10)° γ=90.00°
Diethyl 2-[phenyl(pyrazol-1-yl)methyl]propanedioate
C17H20N2O4
Acta Crystallographica Section E (2010) 66, 5 o1014
a=19.6279(8)Å b=8.1538(3)Å c=21.6002(9)Å
α=90.00° β=104.675(2)° γ=90.00°
3,4-Dimethyl-1<i>H</i>-1,2,4-triazepino[2,3-<i>a</i>]benzimidazol- 2(3<i>H</i>)-one
C12H12N4O
Acta Crystallographica Section E (2010) 66, 5 o1093
a=7.2899(3)Å b=14.4888(5)Å c=10.9932(4)Å
α=90.00° β=104.3140(10)° γ=90.00°
1-Isopropenyl-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one
C10H10N2O
Acta Crystallographica Section E (2010) 66, 6 o1409
a=15.8724(2)Å b=6.09710(10)Å c=17.9313(3)Å
α=90.00° β=90.961(2)° γ=90.00°
4-Methyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one monohydrate
C10H10N2O,H2O
Acta Crystallographica Section E (2010) 66, 6 o1408
a=4.90130(10)Å b=7.31480(10)Å c=13.5688(2)Å
α=85.3750(10)° β=83.9590(10)° γ=83.8070(10)°
3-Benzyl-6-bromo-2-(2-furyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C17H12BrN3O
Acta Crystallographica Section E (2010) 66, 7 o1874
a=15.8422(3)Å b=5.47470(10)Å c=18.4243(3)Å
α=90.00° β=111.5090(10)° γ=90.00°
Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine-5,11-dithione
C12H12N2S2
Acta Crystallographica Section E (2010) 66, 7 o1653
a=13.9831(5)Å b=10.0134(3)Å c=8.2670(3)Å
α=90.00° β=97.0890(10)° γ=90.00°
Diethyl 2-[(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)(4-methoxyphenyl)methyl]propanedioate
C20H26N2O5
Acta Crystallographica Section E (2010) 66, 8 o1965
a=11.9618(3)Å b=7.9681(2)Å c=21.1269(6)Å
α=90.00° β=96.5040(10)° γ=90.00°
4-Allyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate
C15H12BrN3,H2O
Acta Crystallographica Section E (2010) 66, 8 o1903
a=7.43630(10)Å b=9.42380(10)Å c=11.0829(2)Å
α=68.0760(10)° β=74.6370(10)° γ=79.7360(10)°
6-Bromo-1,3-dimethyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C8H8BrN3O
Acta Crystallographica Section E (2010) 66, 8 o1904
a=21.7981(4)Å b=3.99290(10)Å c=20.6636(3)Å
α=90.00° β=95.3980(10)° γ=90.00°
<i>N</i>'-(1-Allyl-2-oxoindolin-3-ylidene)benzohydrazide
C18H15N3O2
Acta Crystallographica Section E (2010) 66, 8 o1905
a=7.5921(2)Å b=15.1968(4)Å c=12.8716(3)Å
α=90.00° β=94.481(2)° γ=90.00°
1-Benzyl-3-methylquinoxalin-2(1<i>H</i>)-one
C16H14N2O
Acta Crystallographica Section E (2010) 66, 8 o1922
a=7.4433(2)Å b=17.5444(5)Å c=18.0598(7)Å
α=118.034(2)° β=100.217(2)° γ=92.7260(10)°
3,4,6-Trimethyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine
C15H15N3
Acta Crystallographica Section E (2010) 66, 8 o1966
a=7.1714(2)Å b=12.0690(4)Å c=14.5491(5)Å
α=90.00° β=101.2510(10)° γ=90.00°
Ethyl 2-(2-oxo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-1-yl)acetate
C19H18N2O3
Acta Crystallographica Section E (2010) 66, 8 o2070
a=12.5198(4)Å b=11.7911(3)Å c=11.2058(3)Å
α=90.00° β=97.843(2)° γ=90.00°
1-[2-(2-Oxo-1,3-oxazolidin-3-yl)ethyl]-4-phenyl-1<i>H</i>- 1,5-benzodiazepin-2(3<i>H</i>)-one
C20H19N3O3
Acta Crystallographica Section E (2010) 66, 8 o2080
a=9.0163(5)Å b=11.6671(6)Å c=16.2019(8)Å
α=90.00° β=90.00° γ=90.00°
Poly[[bis{μ~3~-2-[(3,5-dimethyl-1<i>H</i>-pyrazol-1- yl)(phenyl)methyl]propanedioato}tetrasodium(I)] 7.5-hydrate]
C30H28N4Na4O8,7.5(H2O)
Acta Crystallographica Section E (2010) 66, 8 m1009-m1010
a=31.8211(11)Å b=14.4951(4)Å c=16.1113(5)Å
α=90.00° β=102.139(3)° γ=90.00°
4-(1,3-Benzothiazol-2-yl)-5-methyl-2-phenyl-1-propynyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C20H15N3OS
Acta Crystallographica Section E (2010) 66, 11 o2843
a=4.82210(10)Å b=9.3698(2)Å c=37.6990(9)Å
α=90.00° β=90.00° γ=90.00°
1-Allyl-4-(1,3-benzothiazol-2-yl)-5-methyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C20H17N3OS
Acta Crystallographica Section E (2010) 66, 11 o2842
a=17.8734(5)Å b=10.4297(2)Å c=18.9578(4)Å
α=90.00° β=90.00° γ=90.00°
3-[2-(1<i>H</i>-Benzimidazol-2-ylsulfanyl)ethyl]-1,3-oxazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2010) 66, 12 o3137
a=8.2580(10)Å b=10.0740(10)Å c=29.201(3)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Methoxybenzylidene)-4,4-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one
C20H20O2
Acta Crystallographica Section E (2010) 66, 12 o3067
a=11.8587(3)Å b=8.7536(2)Å c=14.9392(4)Å
α=90.00° β=96.5270(10)° γ=90.00°
1-Allyl-3-methyl-3',5'-diphenylspiro[quinoxaline- 2(1<i>H</i>),2'(3'<i>H</i>)-[1,3,4]thiadiazole]
C25H22N4S
Acta Crystallographica Section E (2010) 66, 12 o3227
a=7.92010(10)Å b=10.07130(10)Å c=13.6642(2)Å
α=78.2960(10)° β=81.2770(10)° γ=89.8260(10)°
Silver indium diphosphate
AgInO7P2
Acta Crystallographica Section E (2011) 67, 1 i2
a=7.4867(3)Å b=8.2620(3)Å c=9.8383(5)Å
α=90.00° β=112.038(2)° γ=90.00°
Indium iron lithium diphosphate
Fe0.49In0.51LiO7P2
Acta Crystallographica Section E (2011) 67, 4 i27
a=4.8698(2)Å b=8.2761(4)Å c=6.9980(3)Å
α=90.00° β=109.650(2)° γ=90.00°
<i>rac</i>-(3<i>S</i>,4<i>S</i>)-3-Hydroxy-4-phenyl-1-[(<i>S</i>)-(3-phenyl- 4,5-dihydro-1,2-oxazol-5-yl)methyl]-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one
C25H23N3O3
Acta Crystallographica Section E (2011) 67, 4 o945-o946
a=8.981(2)Å b=9.044(2)Å c=13.6850(10)Å
α=95.373(10)° β=102.433(10)° γ=100.03(2)°
6-Nitro-2,3-dihydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine- 5,11(10<i>H</i>,11a<i>H</i>)-dione
C12H11N3O4
Acta Crystallographica Section E (2011) 67, 8 o2003
a=10.7364(2)Å b=6.89250(10)Å c=16.3901(3)Å
α=90.00° β=101.8700(10)° γ=90.00°
2-Hydroxy-2,3,5,10,11,11a-hexahydro-1<i>H</i>-pyrrolo[2,1- <i>c</i>][1,4]benzodiazepine-5,11-dione
C12H12N2O3
Acta Crystallographica Section E (2011) 67, 8 o1906
a=4.8366(2)Å b=25.7449(11)Å c=8.5420(4)Å
α=90.00° β=96.509(2)° γ=90.00°
<i>N</i>'-(3-Methylquinoxalin-2-yl)-<i>N</i>'-phenylbenzohydrazide
C22H18N4O
Acta Crystallographica Section E (2011) 67, 6 o1374
a=18.6809(12)Å b=10.5840(8)Å c=9.5860(6)Å
α=90.00° β=100.108(3)° γ=90.00°
<i>N</i>-(7-Ethoxy-1<i>H</i>-indazol-4-yl)-4-methylbenzenesulfonamide
C16H17N3O3S
Acta Crystallographica Section E (2011) 67, 6 o1354
a=16.2579(4)Å b=5.02910(10)Å c=20.4551(5)Å
α=90.00° β=97.2690(10)° γ=90.00°
(2<i>E</i>)-4-<i>tert</i>-butyl-2-(4-methoxybenzylidene)-3,4- dihydronaphthalen-1(2<i>H</i>)-one
C22H24O2
Acta Crystallographica Section E (2011) 67, 7 o1828
a=11.2265(2)Å b=21.7630(5)Å c=14.8001(4)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-2-Benzylidene-4-ethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one
C19H18O
Acta Crystallographica Section E (2011) 67, 7 o1700
a=11.7997(8)Å b=8.9020(6)Å c=13.9912(9)Å
α=90.00° β=94.214(4)° γ=90.00°
4-<i>tert</i>-Butyl-3',4'-bis(4-methylphenyl)-3,4-dihydro- 1<i>H</i>,4'<i>H</i>-spiro[naphthalene-2,5'-[1,2]oxazol]-1-one
C30H31NO2
Acta Crystallographica Section E (2011) 67, 7 o1862
a=6.9158(2)Å b=25.0737(5)Å c=13.8747(3)Å
α=90.00° β=94.3590(10)° γ=90.00°
6-Methyl-2-phenyl-4,5-dihydropyridazin-3(2<i>H</i>)-one
C11H12N2O
Acta Crystallographica Section E (2011) 67, 7 o1709
a=6.4151(2)Å b=7.9010(2)Å c=10.1888(3)Å
α=90.00° β=106.6070(10)° γ=90.00°
<i>N</i>-[7-Ethoxy-1-(prop-2-en-1-yl)-1<i>H</i>-indazol-4-yl]-4- methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2011) 67, 7 o1561
a=8.2208(3)Å b=10.4985(4)Å c=11.9655(5)Å
α=108.814(2)° β=92.346(2)° γ=107.500(2)°
5-(Pyridin-4-ylmethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin- 4(5<i>H</i>)-one
C11H9N5O
Acta Crystallographica Section E (2011) 67, 8 o1926
a=4.6371(3)Å b=19.2731(10)Å c=5.8593(3)Å
α=90.00° β=102.498(2)° γ=90.00°
Silver diaquanickel(II) <i>catena</i>-borodiphosphate(V) hydrate
Ag0.57BH5.33Ni1.22O10.67P2
Acta Crystallographica Section E (2011) 67, 8 i44
a=9.3848(6)Å b=9.3848(6)Å c=15.8411(18)Å
α=90.00° β=90.00° γ=120.00°
<i>N</i>-[7-Ethoxy-2-(prop-2-en-1-yl)-2<i>H</i>-indazol-6-yl]-4- methylbenzenesulfonamide
C19H21N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3211
a=10.1459(7)Å b=9.9506(7)Å c=18.3720(13)Å
α=90.00° β=95.097(3)° γ=90.00°
<i>N</i>-(2-Formylphenyl)-4-methoxy-<i>N</i>-(4- methoxyphenylsulfonyl)benzenesulfonamide
C21H19NO7S2
Acta Crystallographica Section E (2011) 67, 12 o3304
a=9.0559(3)Å b=25.8904(10)Å c=9.3844(3)Å
α=90.00° β=103.423(2)° γ=90.00°
<i>catena</i>-poly[[chlorido(thiourea-κ<i>S</i>)copper(I)]-μ-thiourea- κ^2^<i>S</i>:<i>S</i>]
C2H8ClCuN4S2
Acta Crystallographica Section E (2012) 68, 3 m260-m261
a=5.8043(2)Å b=8.1292(3)Å c=35.9657(12)Å
α=90.00° β=92.326(2)° γ=90.00°
(2<i>RS</i>,4'<i>RS</i>)-3'-(3-Chloro-4-methoxyphenyl)-4'-phenyl-4'<i>H</i>- spiro[indene-2,5'-isoxazol]-1(3<i>H</i>)-one ethanol monosolvate
C23H17ClN2O3,C2H6O
Acta Crystallographica Section E (2011) 67, 9 o2434
a=8.7112(2)Å b=11.3051(2)Å c=22.5913(5)Å
α=90.00° β=90.00° γ=90.00°
(3<i>R</i>,4<i>S</i>)-3,4,8-Trihydroxy-1,2,3,4-tetrahydronaphthalen-1-one monohydrate
C10H10O4,H2O
Acta Crystallographica Section E (2012) 68, 6 o1874
a=4.6430(4)Å b=14.3904(11)Å c=14.4976(10)Å
α=90.00° β=90.00° γ=90.00°
5-Bromo-1-(prop-2-en-1-yl)-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C11H8BrNO2
Acta Crystallographica Section E (2012) 68, 1 o240
a=31.3411(5)Å b=7.89950(10)Å c=8.27160(10)Å
α=90.00° β=90.00° γ=90.00°
3-{2-[(3-{(<i>E</i>)-2-[4-(Dimethylamino)phenyl]ethenyl}quinoxalin-2- yl)oxy]ethyl}-1,3-oxazolidin-2-one monohydrate
C23H24N4O3,H2O
Acta Crystallographica Section E (2012) 68, 1 o241
a=7.209800(10)Å b=23.3271(4)Å c=12.3994(2)Å
α=90.00° β=98.1190(10)° γ=90.00°
(Diaminomethylidene)sulfonium chloride--thiourea (3/2)
3(CH5N2S),3(Cl),2(CH4N2S)
Acta Crystallographica Section E (2012) 68, 2 o257
a=16.3469(6)Å b=8.9579(3)Å c=16.1505(5)Å
α=90.00° β=109.105(2)° γ=90.00°
2-Phenylthieno[2,3-<i>b</i>]quinoxaline
C16H10N2S
Acta Crystallographica Section E (2012) 68, 2 o396
a=6.3875(3)Å b=16.2896(8)Å c=11.6054(6)Å
α=90.00° β=96.039(3)° γ=90.00°
Silver(I) diaquamagnesium <i>catena</i>-borodiphosphate(V) monohydrate
AgBH6MgO11P2
Acta Crystallographica Section E (2011) 67, 6 i39
a=9.4577(4)Å b=9.4577(4)Å c=15.8301(13)Å
α=90.00° β=90.00° γ=120.00°
3'-(4-Methoxyphenyl)-4'-phenyl-3<i>H</i>,4'<i>H</i>-spiro[1-benzothiophene- 2,5'-isoxazol]-3-one
C23H17NO3S
Acta Crystallographica Section E (2011) 67, 7 o1850
a=9.3644(13)Å b=9.8132(14)Å c=11.1502(15)Å
α=103.575(8)° β=90.360(8)° γ=106.089(8)°
Ethyl 2-amino-4-phenyl-4<i>H</i>-1-benzothieno[3,2-<i>b</i>]pyran-3-carboxylate
C20H17NO3S
Acta Crystallographica Section E (2011) 67, 8 o2106
a=8.6612(3)Å b=5.9156(2)Å c=32.3008(10)Å
α=90.00° β=94.962(2)° γ=90.00°
5-Acetyl-3-hydroxy-4-phenyl-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one
C17H16N2O3
Acta Crystallographica Section E (2011) 67, 12 o3337
a=8.97100(10)Å b=9.31420(10)Å c=9.41290(10)Å
α=81.5630(10)° β=68.9210(10)° γ=80.1460(10)°
Silver diaquacobalt(II) <i>catena</i>-borodiphosphate(V) hydrate
Ag0.79BCo1.11H5.33O10.67P2
Acta Crystallographica Section E (2012) 68, 1 i3-i4
a=9.4321(11)Å b=9.4321(11)Å c=15.750(4)Å
α=90.00° β=90.00° γ=120.00°
Dichloridobis(thiourea-κ<i>S</i>)nickel(II)
C2H8Cl2N4NiS2
Acta Crystallographica Section E (2012) 68, 3 m314
a=8.1578(3)Å b=11.8183(5)Å c=10.8526(6)Å
α=90.00° β=103.869(2)° γ=90.00°
Ethyl 3-[7-ethoxy-6-(4-methoxybenzenesulfonamido)-2<i>H</i>-indazol-2-yl]propanoate
C21H25N3O6S
Acta Crystallographica Section E (2012) 68, 4 o931
a=9.1163(4)Å b=10.9161(5)Å c=11.2959(5)Å
α=77.259(2)° β=77.364(2)° γ=88.562(2)°